Markets:

Overview

News

Currencies

International

Treasuries

Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

5.930 -0.200 (-3.26%)

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Capricor Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Discover the top movers in Friday's pre-market session. ↗

August 14, 2026

Via Chartmill

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

August 13, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Capricor Therapeutics Q2 Earnings Call Highlights ↗

August 13, 2026

Capricor Therapeutics (NASDAQ:CAPR) said its biologics license application for deramiocel remains under U.S. Food and Drug Administration review, while the company prepares to submit an amendment...

Via MarketBeat

Topics Earnings

Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026

August 13, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 13, 2026

Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session. The company's market cap stands at $2.9 million. Capricor Therapeutics (NASDAQ:CAPR) stock moved upwards...

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

August 13, 2026

Via Chartmill

Capricor Therapeutics Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Capricor Therapeutics (NASDAQ:CAPR) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga...

Via Benzinga

Topics Earnings

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 13, 2026

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 13, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

Topics Lawsuit

Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 28, 2026 Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)

August 13, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

August 12, 2026

From SkyMedia, LLC

Via GlobeNewswire

Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026

August 12, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

CAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm

August 12, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026

August 12, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

August 12, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 11, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

CAPR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

August 11, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

August 11, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

August 11, 2026

From Pomerantz LLP

Via GlobeNewswire

CAPR INVESTOR ALERT: Capricor Therapeutics Securities Class Action Filed; September 28, 2026 Lead Plaintiff Deadline - Kehoe Law Firm

August 11, 2026

Philadelphia, Pennsylvania--(Newsfile Corp. - August 11, 2026) - Kehoe Law Firm, P.C. announces that a securities class action lawsuit has...

Via Newsfile

Topics Fraud Lawsuit Whistleblower

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026

August 11, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

August 11, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Robbins LLP Urges CAPR Stockholders Who Lost Money Investing in Capricor Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action

August 11, 2026

San Diego, California--(Newsfile Corp. - August 11, 2026) - Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise...

Via Newsfile

Topics Lawsuit

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026

August 10, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 10, 2026

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 10, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

Topics Lawsuit

Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 28, 2026

August 10, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and Lead Plaintiff Deadline on September 28, 2026

August 07, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 07, 2026

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

Topics Lawsuit

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

August 07, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

August 07, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

August 07, 2026

From SkyMedia, LLC

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.